Research Article: A fatal course of COVID-19 during the Omicron surge: can you estimate your patients’ SARS-CoV-2 immune status?
Introduction:
The COVID-19 (coronavirus disease-19) pandemic is less present in the public debate, and pandemic-related restrictions have also been reduced steadily—particularly during the Omicron surge. This variant of the severe acute respiratory syndrome virus-2 (SARS-CoV-2) is thought to be less affecting the patients overall. However, rates of up to 7.8% of severe courses have been described especially in patients with hematological malignancies [1].
Read more